| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.1M | +135.8% | +742.5% |
| R&D Expense | $14.3M | -6.6% | +33.1% |
| SG&A Expense | $6.7M | -6.3% | +5.8% |
| Operating Income | -$1.9M | +86.6% | +86.9% |
| Net Income | -$16.3M | -2.8% | -16.2% |
| EPS (Basic) | -$0.11 | +31.3% | +50.0% |
| EPS (Diluted) | -$0.11 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $103.8M | -14.6% | +69.4% |
| Current Assets | $124.1M | +0.3% | +96.0% |
| Total Assets | $133.7M | -0.1% | +79.1% |
| Current Liabilities | $56.4M | +5.9% | +48.3% |
| Total Liabilities | $141.8M | +11.9% | +164.1% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | — |
| Capital Expenditures | $423K | — | — |
| Investing Cash Flow | -$423K | — | — |
| Financing Cash Flow | $51.9M | — | — |
| Free Cash Flow | -$3.4M | — | — |
| +31.3% |
| +50.0% |
| -$8.1M |
| -214.5% |
| -138.6% |